-ActRII Activin-ActRII Antagonists and Uses for Treating Anemia

摘要

Methods for the treatment of a subject of any mammalian anemia, anemia requiring RBC transfusion, low or intermediate-1-risk myelodysplastic syndrome (MDS), and / or non-proliferative chronic bone marrow mononuclear leukemia (CMML) The method comprising administering an Actin-ActRII signal transduction inhibitor to a subject in need of treatment.